These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Haptic Feedback Manipulation During Botulinum Toxin Injection Therapy for Focal Hand Dystonia Patients: A Possible New Assistive Strategy. Atashzar SF; Shahbazi M; Ward C; Samotus O; Delrobaei M; Rahimi F; Lee J; Jackman M; Jog MS; Patel RV IEEE Trans Haptics; 2016; 9(4):523-535. PubMed ID: 27552765 [TBL] [Abstract][Full Text] [Related]
12. OnabotulinumtoxinA for the Treatment of Poststroke Distal Lower Limb Spasticity: A Randomized Trial. Wein T; Esquenazi A; Jost WH; Ward AB; Pan G; Dimitrova R PM R; 2018 Jul; 10(7):693-703. PubMed ID: 29330071 [TBL] [Abstract][Full Text] [Related]
13. Botulinum toxin injection for hypertonicity of the upper extremity within 12 weeks after stroke: a randomized controlled trial. Rosales RL; Kong KH; Goh KJ; Kumthornthip W; Mok VC; Delgado-De Los Santos MM; Chua KS; Abdullah SJ; Zakine B; Maisonobe P; Magis A; Wong KS Neurorehabil Neural Repair; 2012 Sep; 26(7):812-21. PubMed ID: 22371239 [TBL] [Abstract][Full Text] [Related]
14. Botulinum toxin type A (BOTOX) for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial. Mathew NT; Frishberg BM; Gawel M; Dimitrova R; Gibson J; Turkel C; Headache; 2005 Apr; 45(4):293-307. PubMed ID: 15836565 [TBL] [Abstract][Full Text] [Related]
15. OnabotulinumtoxinA 100 U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary incontinence: a randomised, double-blind, placebo-controlled trial. Chapple C; Sievert KD; MacDiarmid S; Khullar V; Radziszewski P; Nardo C; Thompson C; Zhou J; Haag-Molkenteller C Eur Urol; 2013 Aug; 64(2):249-56. PubMed ID: 23608668 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of single-dose onabotulinumtoxinA in the treatment of symptoms of osteoarthritis of the knee: results of a placebo-controlled, double-blind study. McAlindon TE; Schmidt U; Bugarin D; Abrams S; Geib T; DeGryse RE; Kim K; Schnitzer TJ Osteoarthritis Cartilage; 2018 Oct; 26(10):1291-1299. PubMed ID: 29753118 [TBL] [Abstract][Full Text] [Related]
17. Pilot Single-Blind Trial of AbobotulinumtoxinA in Oromandibular Dystonia. Scorr LM; Silver MR; Hanfelt J; Sperin E; Freeman A; Jinnah HA; Factor SA Neurotherapeutics; 2018 Apr; 15(2):452-458. PubMed ID: 29542022 [TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of repeated injections of botulinum toxin A in peripheral neuropathic pain (BOTNEP): a randomised, double-blind, placebo-controlled trial. Attal N; de Andrade DC; Adam F; Ranoux D; Teixeira MJ; Galhardoni R; Raicher I; Üçeyler N; Sommer C; Bouhassira D Lancet Neurol; 2016 May; 15(6):555-65. PubMed ID: 26947719 [TBL] [Abstract][Full Text] [Related]
19. Oral appliances in the treatment of oromandibular dystonia: a systematic review. De Meyer M; Vereecke L; Bottenberg P; Jacquet W; Sims AB; Santens P Acta Neurol Belg; 2020 Aug; 120(4):831-836. PubMed ID: 32594465 [TBL] [Abstract][Full Text] [Related]
20. The clinical utility of botulinum toxin injections targeted at the motor endplate zone in cervical dystonia. Delnooz CC; Veugen LC; Pasman JW; Lapatki BG; van Dijk JP; van de Warrenburg BP Eur J Neurol; 2014 Dec; 21(12):1486-e98. PubMed ID: 25060697 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]